Search Results - Vidisheva, Aleksandra

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Safety of BTZ retreatment for patients with low-grade peripheral neuropathy during the initial treatment

    Safety of BTZ retreatment for patients with low-grade peripheral neuropathy during the initial treatment by Vidisheva, Aleksandra P., Wang, James, Spektor, Tanya M., Bitran, Jacob D, Lutzky, Jose, Tabbara, Imad A., Ye, Joseph Z., Ailawadhi, Sikander, Stampleman, Laura V., Steis, Ronald G., Moezi, Mehdi M., Swift, Regina A., Maluso, Tina M, Udd, Kyle A, Eshaghian, Shahrooz, Nassir, Youram, Berenson, James R.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    The Total Lifetime Cost of Treating Patients (Pts) with CLL in the United States (US)

    The Total Lifetime Cost of Treating Patients (Pts) with CLL in the United States (US) by Awan, Farrukh T., Vidisheva, Aleksandra, Saeedian, Matia, Kurt, Murat, Tiwana, Simran K., Priyadarshini, Masoom

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Low serum vitamin D occurs commonly among multiple myeloma patients treated with bortezomib and/or thalidomide and is associated with severe neuropathy

    Low serum vitamin D occurs commonly among multiple myeloma patients treated with bortezomib and/or thalidomide and is associated with severe neuropathy by Wang, James, Udd, Kyle A., Vidisheva, Aleksandra, Swift, Regina A., Spektor, Tanya M., Bravin, Eric, Ibrahim, Emad, Treisman, Jonathan, Masri, Mohammed, Berenson, James R.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    The anti-myeloma effects of the selective JAK1 inhibitor (INCB052793) alone and in combination in vitro and in vivo

    The anti-myeloma effects of the selective JAK1 inhibitor (INCB052793) alone and in combination in vitro and in vivo by Sanchez, Eric, Li, Mingjie, Patil, Saurabh, Soof, Camilia M., Nosrati, Jason D., Schlossberg, Remy E., Vidisheva, Aleksandra, Tanenbaum, Edward J., Hekmati, Tara, Zahab, Brian, Wang, Cathy, Tang, George, Chen, Haiming, Berenson, James R.

    Published in Annals of hematology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Elotuzumab and dexamethasone for relapsed or refractory multiple myeloma patients: A retrospective study

    Elotuzumab and dexamethasone for relapsed or refractory multiple myeloma patients: A retrospective study by Gross, Zachary, Rahbari, Ashkon, Wirtschafter, Eric, Spektor, Tanya M., Udd, Kyle A., Bujarski, Sean, Ghermezi, Michael, Nosrati, Jason D., Vidisheva, Aleksandra, Eades, Benjamin, Cecchi, Gary, Maluso, Tina, Swift, Regina, Berenson, James R.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Elotuzumab and dexamethasone for relapsed or refractory multiple myeloma patients: A retrospective study

    Elotuzumab and dexamethasone for relapsed or refractory multiple myeloma patients: A retrospective study by Gross, Zachary, Rahbari, Ashkon, Wirtschafter, Eric, Spektor, Tanya M, Udd, Kyle A, Bujarski, Sean, Ghermezi, Michael, Nosrati, Jason D, Vidisheva, Aleksandra, Eades, Benjamin, Cecchi, Gary, Maluso, Tina, Swift, Regina, Berenson, James R

    Get full text
    Report
    Save to List
    Saved in:

Search Tools: